Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongchuan Jin

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Thescientificworldjournal|February 23, 2013
MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implicationsJie Sun, Haiqi Lu, Xian Wang, et al.
Biomed Research International|May 8, 2014
mTOR in viral hepatitis and hepatocellular carcinoma: function and treatmentZhuo Wang, Wei Jin, Hongchuan Jin, et al.
Plos One|June 30, 2017
The association between gout and cataract risk: A meta-analysisChenqi Luo, Xinyi Chen, Hongchuan Jin, et al.
Biomed Research International|April 16, 2015
MicroRNAs as potential biomarkers in cancer: opportunities and challengesHuiyin Lan, Haiqi Lu, Xian Wang, et al.
Oncology Letters|January 21, 2016
Function and clinical potential of microRNAs in hepatocellular carcinomaLijuan Wang, Yongfang Yue, Xian Wang, et al.
Scientific Reports|April 12, 2016
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cellsHuiyin Lan, Zaiming Tang, Hongchuan Jin, et al.
Signal Transduction and Targeted Therapy|February 18, 2021
The regulation of protein translation and its implications for cancerPing Song, Fan Yang, Hongchuan Jin, et al.
Cell Death & Disease|July 23, 2022
RNA-based therapeutics: an overview and prospectusYiran Zhu, Liyuan Zhu, Xian Wang, et al.
Nature|August 4, 2006
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphataseHongchuan Jin, Tobias Sperka, Peter Herrlich, et al.
American Journal of Cancer Research|December 7, 2021
Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancerNeelum Aziz Yousafzai, Hongchuan Jin, Mujib Ullah, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Thescientificworldjournal|February 23, 2013
MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implicationsJie Sun, Haiqi Lu, Xian Wang, et al.
Biomed Research International|May 8, 2014
mTOR in viral hepatitis and hepatocellular carcinoma: function and treatmentZhuo Wang, Wei Jin, Hongchuan Jin, et al.
Plos One|June 30, 2017
The association between gout and cataract risk: A meta-analysisChenqi Luo, Xinyi Chen, Hongchuan Jin, et al.
Biomed Research International|April 16, 2015
MicroRNAs as potential biomarkers in cancer: opportunities and challengesHuiyin Lan, Haiqi Lu, Xian Wang, et al.
Oncology Letters|January 21, 2016
Function and clinical potential of microRNAs in hepatocellular carcinomaLijuan Wang, Yongfang Yue, Xian Wang, et al.
Scientific Reports|April 12, 2016
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cellsHuiyin Lan, Zaiming Tang, Hongchuan Jin, et al.
Signal Transduction and Targeted Therapy|February 18, 2021
The regulation of protein translation and its implications for cancerPing Song, Fan Yang, Hongchuan Jin, et al.
Cell Death & Disease|July 23, 2022
RNA-based therapeutics: an overview and prospectusYiran Zhu, Liyuan Zhu, Xian Wang, et al.
Nature|August 4, 2006
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphataseHongchuan Jin, Tobias Sperka, Peter Herrlich, et al.
American Journal of Cancer Research|December 7, 2021
Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancerNeelum Aziz Yousafzai, Hongchuan Jin, Mujib Ullah, et al.
Pageof 16